Evaluation of the Efficacy and Safety of a Glycosaminoglycan-Peptide Complex in the Treatment of Knee Osteoarthritis in Patients With Previous Inefficiency of Slow-Release Oral Anti-Inflammatory Drugs (The Multicenter Open-Label Study Primula: Use of Rumalon® With Initially Small Success in the Treatment of Osteoarthritis)

Каратеев, А. Е.; Алексеева, Л. И.; Лила, А. М.; Макаров, С. А.; Чичасова, Н. В.; Зонова, Е. В.; Кашеварова, Н. Г.; Таскина, Е. А.; Шарапова, Е. П.

doi:10.14412/1995-4484-2018-22-27

rsp

2018

DOI: 10.14412/1995-4484-2018-22-27

|View full text |Cite

Evaluation of the Efficacy and Safety of a Glycosaminoglycan-Peptide Complex in the Treatment of Knee Osteoarthritis in Patients With Previous Inefficiency of Slow-Release Oral Anti-Inflammatory Drugs (The Multicenter Open-Label Study Primula: Use of Rumalon® With Initially Small Success in the Treatment of Osteoarthritis)

А. Е. Каратеев¹,

Л. И. Алексеева²,

А. М. Лила³

et al.

Abstract: О р и г и н а л ь н ы е и с с л е д о в а н и я 1 ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой» Москва, Россия; 2 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России (Сеченовский университет),

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study

Алексеева

Таскина²,

Кашеварова³

et al. 2021

Sovremennaâ revmatologiâ

Self Cite

View full text Add to dashboard Cite

Objective: to evaluate the efficacy and safety of glycosaminoglycan-peptide complex (GPC, Rumalon) used in patients with knee osteoarthritis (OA) and comorbidities (hypertension and/or type 2 diabetes mellitus (T2DM).Patients and methods: A 10-month multicenter (13 centers from 10 subjects of the Russian Federation) prospective study included 179 patients with Stages II–III primary tibiofemoral knee OA and comorbidity, a walking pain intensity of ≥40 mm on a visual analogue scale (VAS), and a need for nonsteroidal anti-inflammatory drugs (for at least 30 days in the previous 3 months). The efficiency of treatment was evaluated from the changes in VAS scores for knee pain intensity during walking, the overall WOMAC score and scores of its individual indicators, laboratory parameters, and ultrasound data. All the patients received 2 cycles of GPC treatment with 25 injections, by following the manufacturer's instructions.Results and discussion. Even at 2 months after starting the treatment, there was a statistically significant reduction in pain during walking from 60 (50–69) to 40 (27–53.5) mm on the VAS (p< 0.05), which persisted during the follow-up period. A similar pattern was found when assessing the WOMAC index and its components. The drug demonstrated an anti-inflammatory effect: a decrease in the number of patients with synovitis from 55.7 to 39.2% (p=0.02), the level of high-sensitivity C-reactive protein (hsCRP) from 3.2 (1.3–6.2) to 2.6 (1.2–5.7) mg/l (p< 0.05). GPC was ascertained to have a safety profile.Conclusion. The data of this study confirm the good therapeutic effect and safety of GPC Rumalon in knee OA patients with hypertension and/or T2DM. The drug is shown to have a rapid analgesic and anti-inflammatory effect, as well as a positive influence on all clinical manifestations of OA.

show abstract

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study

Алексеева

Таскина²,

Кашеварова³

et al. 2021

Sovremennaâ revmatologiâ

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cited by 1 publication

References 17 publications

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study

Contact Info

Product

Resources

About